Terms: = Lung cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2
682 results:
1. TAZ deficiency impairs the autophagy-lysosomal pathway through nrf2 dysregulation and lysosomal dysfunction.
Kim HK; Jeong H; Jeong MG; Won HY; Lee G; Bae SH; Nam M; Lee SH; Hwang GS; Hwang ES
Int J Biol Sci; 2024; 20(7):2592-2606. PubMed ID: 38725855
[TBL] [Abstract] [Full Text] [Related]
2. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant lung cancer.
Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells.
Salerno L; Notaro A; Consoli V; Affranchi F; Pittalà V; Sorrenti V; Vanella L; Giuliano M; Intagliata S
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2337191. PubMed ID: 38634597
[TBL] [Abstract] [Full Text] [Related]
4. Redox
Wei XW; Lu C; Zhang YC; Fan X; Xu CR; Chen ZH; Wang F; Yang XR; Deng JY; Yang MY; Gou Q; Mei SQ; Luo WC; Zhong RW; Zhong WZ; Yang JJ; Zhang XC; Tu HY; Wu YL; Zhou Q
Oncoimmunology; 2024; 13(1):2340154. PubMed ID: 38601319
[TBL] [Abstract] [Full Text] [Related]
5. MAPK15 controls cellular responses to oxidative stress by regulating nrf2 activity and expression of its downstream target genes.
Franci L; Vallini G; Bertolino FM; Cicaloni V; Inzalaco G; Cicogni M; Tinti L; Calabrese L; Barone V; Salvini L; Rubegni P; Galvagni F; Chiariello M
Redox Biol; 2024 Jun; 72():103131. PubMed ID: 38555711
[TBL] [Abstract] [Full Text] [Related]
6.
Occhiuto CJ; Liby KT
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542481
[TBL] [Abstract] [Full Text] [Related]
7. Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in
Pillai R; LeBoeuf SE; Hao Y; New C; Blum JLE; Rashidfarrokhi A; Huang SM; Bahamon C; Wu WL; Karadal-Ferrena B; Herrera A; Ivanova E; Cross M; Bossowski JP; Ding H; Hayashi M; Rajalingam S; Karakousi T; Sayin VI; Khanna KM; Wong KK; Wild R; Tsirigos A; Poirier JT; Rudin CM; Davidson SM; Koralov SB; Papagiannakopoulos T
Sci Adv; 2024 Mar; 10(13):eadm9859. PubMed ID: 38536921
[TBL] [Abstract] [Full Text] [Related]
8. Glutamine antagonists may KEAP lung cancer in check.
Blatt EB; DeBerardinis RJ
Sci Adv; 2024 Mar; 10(13):eado7808. PubMed ID: 38536918
[TBL] [Abstract] [Full Text] [Related]
9. AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis.
Deng B; Liu F; Chen N; Li X; Lei J; Chen N; Wu J; Wang X; Lu J; Fang M; Chen A; Zhang Z; He B; Yan M; Zhang Y; Wang Z; Liu Q
Cell Death Dis; 2024 Mar; 15(3):233. PubMed ID: 38521813
[TBL] [Abstract] [Full Text] [Related]
10. nrf2 regulates EGF stability through OTUD4 in lung adenocarcinoma.
Hu S; Yuan Y; Yan R; Xie H; Cai R; Xu J
Biochem Biophys Res Commun; 2024 May; 708():149798. PubMed ID: 38518721
[TBL] [Abstract] [Full Text] [Related]
11. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants.
Jomova K; Alomar SY; Alwasel SH; Nepovimova E; Kuca K; Valko M
Arch Toxicol; 2024 May; 98(5):1323-1367. PubMed ID: 38483584
[TBL] [Abstract] [Full Text] [Related]
12. Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer.
Sitthideatphaiboon P; Nantavithya C; Chantranuwat P; Vinayanuwattikun C; Sriuranpong V
Sci Rep; 2024 Mar; 14(1):6146. PubMed ID: 38480816
[TBL] [Abstract] [Full Text] [Related]
13. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/nrf2 axis.
Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
[TBL] [Abstract] [Full Text] [Related]
14. YES1 as a potential target to overcome drug resistance in EGFR-deregulated non-small cell lung cancer.
Kook E; Lee J; Kim DH
Arch Toxicol; 2024 May; 98(5):1437-1455. PubMed ID: 38443724
[TBL] [Abstract] [Full Text] [Related]
15. 5-Methylcytosine transferase NSUN2 drives nrf2-mediated ferroptosis resistance in non-small cell lung cancer.
Chen Y; Jiang Z; Zhang C; Zhang L; Chen H; Xiao N; Bai L; Liu H; Wan J
J Biol Chem; 2024 Apr; 300(4):106793. PubMed ID: 38403250
[TBL] [Abstract] [Full Text] [Related]
16. SLC15A3 plays a crucial role in pulmonary fibrosis by regulating macrophage oxidative stress.
Luo J; Li P; Dong M; Zhang Y; Lu S; Chen M; Zhou H; Lin N; Jiang H; Wang Y
Cell Death Differ; 2024 Apr; 31(4):417-430. PubMed ID: 38374230
[TBL] [Abstract] [Full Text] [Related]
17. Cephaeline promotes ferroptosis by targeting nrf2 to exert anti-lung cancer efficacy.
Chen P; Ye Q; Liang S; Zeng L
Pharm Biol; 2024 Dec; 62(1):195-206. PubMed ID: 38339810
[TBL] [Abstract] [Full Text] [Related]
18. PM
Li R; Zhao C; Zhang Y; Huang W; Wang J; Cao G; Cai Z
Toxicol Mech Methods; 2024 Jun; 34(5):517-526. PubMed ID: 38293967
[TBL] [Abstract] [Full Text] [Related]
19. Glutathione Depletion-Induced Versatile Nanomedicine for Potentiating the Ferroptosis to Overcome Solid Tumor Radioresistance and Enhance Immunotherapy.
Song H; Sun H; He N; Xu C; Du L; Ji K; Wang J; Zhang M; Gu Y; Wang Y; Liu Q
Adv Healthc Mater; 2024 Apr; 13(9):e2303412. PubMed ID: 38245863
[TBL] [Abstract] [Full Text] [Related]
20. PSMD12 promotes non-small cell lung cancer progression through activating the nrf2/TrxR1 pathway.
Lv J; Ma S; Wang X; Dang J; Ma F
Genes Genomics; 2024 Mar; 46(3):263-277. PubMed ID: 38243044
[TBL] [Abstract] [Full Text] [Related]
[Next]
